FDA Proposes Rule for Appealing CDRH Decisions
By Michael Mezher -
Published 16 January 2018
The US Food and Drug Administration (FDA) on Tuesday proposed a new rule for appealing certain decisions about medical devices made by the Center for Devices and Radiological Health (CDRH).
Categories: News, US, CDRH, Medical Devices, Submission and registration
Tags: Significant Decisions, Supervisory Review, Appeals